Commercial-stage biopharma developing next-generation programmed CAR T-cell therapies for cancer and autoimmune disease; UCL spin-out listed on NASDAQ (AUTL).
Locations
London, United Kingdom (Headquarters)
The MediaWorks, 191 Wood Lane, White City, London, Greater London, W12 7FP, United Kingdom